Avid Bioservices Welcomes Rich McAvoy as New CBO
Seasoned business and finance leader brings disciplined growth mindset to support Avid's next phase of expansion and client execution
Avid Bioservices, a leading contract development and manufacturing organization (CDMO) known for its expertise in biopharmaceuticals, has exciting news: Rich McAvoy has been appointed as Chief Business Officer (CBO). This strategic move is expected to bolster Avid's growth and enhance client service as the company continues to evolve.
Institute’s Commitment to Excellence
Rich McAvoy, recognized for his extensive experience in strategic investment management, operational finance, accounting, legal, compliance, and risk management, steps into this pivotal role at an exciting time for Avid. He is tasked with guiding the company’s growth strategy, focusing on disciplined execution and scalable operations to achieve outstanding client delivery.
During a recent statement, Kenneth Bilenberg, CEO of Avid Bioservices, articulated the organization’s forward-looking vision, highlighting, "As we transition into our next chapter of growth, we're dedicated to scaling our operations to improve execution and elevate the client experience. Rich McAvoy is a thoughtful leader with a proven reputation for establishing robust organizations that ensure reliable delivery. His expertise in linking strategy to execution will be invaluable during this period of expansion. We are thrilled to welcome him onboard."
Seizing Market Opportunities
McAvoy joins Avid at a crucial moment in the biopharmaceutical landscape. The industry is pressing ahead, with many firms scrutinizing strategies to reinforce supply chain resilience amid evolving global challenges. Factors such as geopolitical fluctuations and a renewed concentration on domestic manufacturing will significantly influence how biopharmaceutical companies like Avid operate in the future.
"With Avid's prominent reputation for quality and delivery, I am energized to be part of this team during such a pivotal phase. My primary goal is to maintain disciplined execution, ensuring we consistently deliver on time while also fostering an exceptional customer experience," said McAvoy. He emphasized that consistent delivery would be a key differentiator, positioning Avid as a preferred partner in the industry.
Building a Stronger Leadership Team
McAvoy's arrival further enhances the leadership at Avid Bioservices as the organization gears up to broaden its capabilities and deepen partnerships with biopharmaceutical innovators. Avid is steadfast in its commitment to helping customers propel critical programs, guaranteeing reliable operations and high-quality CGMP manufacturing services across clinical and commercial supply chains.
About Avid Bioservices?
Avid Bioservices is a prominent global CDMO specializing in mammalian cell-culture manufacturing. Headquartered in the U.S. and holding a flawless track record with the FDA, Avid is a trusted partner for biopharmaceutical innovators across the globe. The organization’s agility and expertise allow it to navigate complex global regulatory environments with ease, catering to both emerging biotech and large pharmaceutical companies. Avid delivers comprehensive solutions from initial development through to commercial supply.
Impressive Metrics
When it comes to achievements, Avid's track record speaks volumes:
- More than 600 batches manufactured
- Over 275 commercial batches delivered globally
- 6+ approved commercial products
- 10 successful regulatory inspections across major agencies
Frequently Asked Questions
Who is Rich McAvoy?
Rich McAvoy is the newly appointed Chief Business Officer (CBO) at Avid Bioservices, tasked with guiding the company’s growth strategy.
What is Avid Bioservices?
Avid Bioservices is a contract development and manufacturing organization specializing in biopharmaceutical products.
Why is McAvoy’s appointment significant?
His experience and leadership are expected to strengthen Avid's operations and improve its execution in delivering services to clients.
What are Avid’s primary services?
Avid provides process development and CGMP manufacturing services for biopharmaceutical products.
How has Avid performed in manufacturing?
Avid boasts over 600 batches manufactured and 275 commercial batches delivered globally, reflecting its reliability and expertise in the industry.
